Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (441-450 of 466) with videos related to

Pageof 47
Sort By:
International Journal of Cancer|March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumabChristos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.
Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancerClay E S Comstock, Michael A Augello, Ruth Pe Benito, et al.
Iscience|September 8, 2023
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectionEva A M Baerends, Astrid K Hvidt, Joanne Reekie, et al.
British Journal of Anaesthesia|April 24, 2016
Effects of using the simplified airway risk index vs usual airway assessment on unanticipated difficult tracheal intubation - a cluster randomized trial with 64,273 participantsA K Nørskov, J Wetterslev, C V Rosenstock, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray ResourceVéronique Ouellet, Andrew Erickson, , et al.
Pageof 47

Showing results (441-450 of 466) with videos related to

Sort By:
Pageof 47
International Journal of Cancer|March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumabChristos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.
Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancerClay E S Comstock, Michael A Augello, Ruth Pe Benito, et al.
Iscience|September 8, 2023
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectionEva A M Baerends, Astrid K Hvidt, Joanne Reekie, et al.
British Journal of Anaesthesia|April 24, 2016
Effects of using the simplified airway risk index vs usual airway assessment on unanticipated difficult tracheal intubation - a cluster randomized trial with 64,273 participantsA K Nørskov, J Wetterslev, C V Rosenstock, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray ResourceVéronique Ouellet, Andrew Erickson, , et al.
Pageof 47